Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China
American Journal of Biomedical and Life Sciences
Volume 8, Issue 2, April 2020, Pages: 41-46
Received: Mar. 31, 2020;
Accepted: Apr. 13, 2020;
Published: Apr. 23, 2020
Views 183 Downloads 249
Ying Wu, Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Bin Pan, Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Yutong Li, Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Jinai He, Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Guohua Huang, Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Qiufeng Li, Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.
Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China, American Journal of Biomedical and Life Sciences.
Vol. 8, No. 2,
2020, pp. 41-46.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020, 382 (8): 727-733.
Huang CL, Wang YM, Li XW, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395 (10223): 497-506.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 Feb 7. doi: 10.1097/CM9.0000000000000744. [Epub ahead of print].
Interim infection prevention and control recommendations for patients with known or patients under investigation for 2019 novel coronavirus (2019-nCoV) in a healthcare setting. https://www.cdc.gov/coron avirus/2019-nCoV/hcp/infec tion-contr ol.html. Accessed 30 Jan 2020.
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011, 81: 85-64.
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019; 11 (1) pii: E59.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395 (10223): 507-513.
She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020, 9 (1): 19.
Li Q, Guan XH, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus infected pneumonia. N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMoa2001316. [Epub ahead of print].
Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importati on and human-to human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020, 382 (9): 872-874.
Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Cell Discov. 2020, 6: 10.
New features of novel coronavirus (2019-nCoV) pneumonia. https://new. qq.com/omn/20200128/20200128A07H4S00.html. Accessed 30 Jan 2020.
Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China-Key Questions for Impact Assessment. N Engl J Med. 2020, 382 (8): 692-694.
WHO statement regarding cluster of pneumonia cases in Wuhan, China. https://www.who.int/china/news/detail/09- 01-2020-who-state.
Chen ZL, Zhang Q, Lu Y, Guo ZM, Zhang X, Zhang WJ, et al. Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China. Chin Med J (Engl). 2020 Feb 28. doi: 10.1097/CM9.0000000000000782. [Epub ahead of print].
Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020, 395 (10225): 689-697.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020, 395 (10223): 514-523.
Cao Y, Li Q, Chen J, Guo X, Miao C, Yang H, Chen Z, Li C. Hospital Emergency Management Plan During the COVID-19 Epidemic. Acad Emerg Med. 2020, Mar 2. doi: 10.1111/acem.13951.[Epub ahead of print].
Chen Q, Liang M, Li Y, Guo J, Fei D, Wang L, He L, Sheng C, Cai Y, Li X, Wang J, Zhang Z. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry. 2020, 18pii: S2215-0366 (20) 30078-X.
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020, 22. pii: dyaa033. doi: 10.1093/ije/dyaa033. [Epub ahead of print].
Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Xiang YT. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020, 18, pii: S2215-0366 (20) 30079-1. doi: 10.1016/S2215-0366(20)30079-1. [Epub ahead of print].
Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, et al. The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk. Can J Psychiatry 2009; 54 (5): 302-11.
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.Int J Antimicrob Agents. 2020 Feb 17: 105924. doi: 10.1016/j.ijantimicag.2020.105924. [Epub ahead of print].
National Health Commission of the People’s Republic of China. Diagnosis and treatment of new coronavirus pneumonia (version 5) http://www.nhc.gov.cn/. Accessed 30 Jan 2020.